Loading...
Indian Pharmaceutical Exporter · #9 for Ceftazidime · $186.2K export value · DGFT Verified
JPC Global is the #9 Indian exporter of Ceftazidime with $186.2K in export value and 18 verified shipments. JPC Global holds a 1.7% market share in Ceftazidime exports across 1 countries. The company exports 6 pharmaceutical products worth $286.9K across 4 therapeutic categories.
| MYANMAR | $397.4K | 24 | 6.5% |
| PHILIPPINES | $352.3K | 31 | 5.8% |
| TAJIKISTAN | $330.0K | 23 | 5.4% |
| NIGERIA | $317.5K | 20 | 5.2% |
| SOUTH AFRICA | $290.4K | 29 | 4.8% |
| KENYA | $255.4K | 31 | 4.2% |
India exports Ceftazidime to 99 countries. The top destination is UKRAINE (16.4%), followed by SUDAN and GHANA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ANANTA MEDICARE UKRAINE LTD. | UKRAINE | $750.0K | 15 |
| BIOMEDIC HEALTHCARE SOLUTION | MYANMAR | $200.0K | 4 |
| E P H K | HUNGARY | $174.3K | 4 |
| OA&J PHARMACEUTICALS LTD. | GHANA | $150.0K | 3 |
| ANANTA MEDICARE UKRAINE LIMITED | UKRAINE | $150.0K | 3 |
| OOO JODAS EXPOIM | RUSSIA | $143.5K | 3 |
| V P G | GERMANY | $137.7K | 5 |
| PLANETPHARMA SA | FRANCE | $129.0K | 12 |
| PRECIOUS TRUST LTD. | NIGERIA | $122.7K | 5 |
| TO THE RECEIVING DEPARTMENT | SOUTH AFRICA | $119.4K | 7 |
India's Ceftazidime is purchased by 360 buyers worldwide. The top buyer is ANANTA MEDICARE UKRAINE LTD. (UKRAINE), followed by BIOMEDIC HEALTHCARE SOLUTION and E P H K.
India exported $4.4M worth of Ceftazidime through 920 shipments from 228 suppliers to 99 countries, serving 360 buyers globally. JPC Global contributes $186.2K to this total, accounting for 1.7% of India's Ceftazidime exports.
JPC Global's average Ceftazidime shipment value is $10.3K per consignment, based on 18 shipments totaling $186.2K.
JPC Global ranks #9 among 228 Indian Ceftazidime exporters with a 1.7% market share. The top 3 exporters are ANANTA MEDICARE LIMITED ($1.1M), VENUS REMEDIES LIMITED ($722.5K), ZEISS PHARMACEUTICALS PRIVATE LIMITED ($400.0K). JPC Global processed 18 shipments to 1 destination countries.
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | BIOCOLL PHARMACEUTICALS PRIVATE LIMITED | $200.0K | 4 | 2 | $50.0K |
| 8 | STRIDES PHARMA SCIENCE LIMITED | $186.5K | 5 | 1 | $37.3K |
| 9 | JPC GLOBAL ★ | $186.2K | 18 | 1 | $10.3K |
| 10 | INJECT CARE PARENTERALS PRIVATE LIMITED | $172.9K | 5 | 2 | $34.6K |
| 11 | EVOLET HEALTHCARE PRIVATE LIMITED | $168.5K | 6 | 1 | $28.1K |
JPC Global ranks #9 among 228 Indian Ceftazidime exporters. Average shipment value of $10.3K compared to the market average of $19.4K. The closest competitors by value are BIOCOLL PHARMACEUTICALS PRIVATE LIMITED and STRIDES PHARMA SCIENCE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 118 | 12.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 102 | 11.1% |
| NHAVA SHEVA SEA (INNSA1) | 88 | 9.6% |
| DELHI AIR | 72 | 7.8% |
| DELHI AIR CARGO ACC (INDEL4) | 62 | 6.7% |
| JNPT/ NHAVA SHEVA SEA | 36 | 3.9% |
| Bombay Air | 35 | 3.8% |
| BANGALORE ACC (INBLR4) | 31 | 3.4% |
JPC Global exports 6 products worth $286.9K. Beyond Ceftazidime, top products include Antitoxin, Tofacitinib, Ibrutinib, Vinblastine, Lomustine. View the complete JPC Global profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ceftazidime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 99+ countries, 360+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for JPC Global's Ceftazidime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JPC Global
Full Company Profile →
6 products · $286.9K total trade · 4 categories
Access shipment-level records, pricing trends, and buyer contacts for JPC Global.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ceftazidime. For current shipment-level data, contact TransData Nexus.